$214 Million is the total value of Foresite Capital Management III, LLC's 17 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 40.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALDR | Sell | Alder BioPharmaceuticals, Inc. | $51,963,000 | +30.0% | 1,585,683 | -0.9% | 24.29% | -11.4% |
| WVE | Sell | WAVE Life Sciences Ltd. | $23,622,000 | +17.7% | 727,496 | -25.0% | 11.04% | -19.8% |
| GBT | Sell | Global Blood Therapeutics, Inc. | $10,501,000 | -8.3% | 455,590 | -34.0% | 4.91% | -37.5% |
| OREX | Sell | Orexigen Therapeutics, Inc. | $844,000 | -22.8% | 254,257 | -90.0% | 0.39% | -47.5% |
| SYRS | Sell | Syros Pharmaceuticals, Inc. | $832,000 | -69.4% | 60,000 | -60.0% | 0.39% | -79.2% |
| BDSI | Sell | BioDelivery Sciences International, Inc. | $127,000 | -23.5% | 47,158 | -32.8% | 0.06% | -48.2% |
| BLCM | Exit | Bellicum Pharmaceuticals, Inc. | $0 | – | -205,990 | -100.0% | -1.83% | – |
| Exit | NeuroDerm Ltd. | $0 | – | -201,469 | -100.0% | -2.25% | – | |
| AVXS | Exit | Avexis, Inc. | $0 | – | -95,173 | -100.0% | -2.48% | – |
| ARDX | Exit | Ardelyx, Inc. | $0 | – | -601,485 | -100.0% | -3.60% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Epizyme, Inc. | 24 | Q3 2021 | 17.6% |
| Acceleron Pharma Inc. | 22 | Q3 2021 | 25.9% |
| CymaBay Therapeutics, Inc. | 20 | Q3 2022 | 17.6% |
| Aerie Pharmaceuticals, Inc. | 18 | Q1 2020 | 33.5% |
| Ascendis Pharma A/S | 17 | Q3 2022 | 47.8% |
| Alder BioPharmaceuticals, Inc. | 16 | Q3 2019 | 27.4% |
| Natera, Inc. | 16 | Q3 2022 | 21.5% |
| Aimmune Therapeutics, Inc. | 16 | Q3 2019 | 8.1% |
| Verona Pharma PLC. | 15 | Q3 2022 | 30.0% |
| WAVE Life Sciences Ltd. | 15 | Q2 2019 | 20.0% |
View Foresite Capital Management III, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
| 4 | 2021-11-03 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 3 | 2021-02-10 |
View Foresite Capital Management III, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.